The cost of Lenvima can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Lenvima. As with all ...

Lenvima (lenvatinib mesylate) was approved and launched for differentiated thyroid cancer in the US, the EU and Japan last year, and earned 1.3bn yen (around $12m) in the first quarter of 2016.

Lenvima is taking on Bayer's Nexavar in liver cancer in Japan – a drug that has been on the market for around a decade. According to Hendler the uptake in Japan has been remarkable, and more ...

Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer. Merck and Eisai on Friday ...

Lenvima/Welireg combination showed the highest ORR (46.9%) and CBR (59%) among treatment arms in advanced ccRCC patients. Median progression-free survival was longest in the Lenvima/Welireg arm at ...

All patients in the study had tumor progression on previous treatment but subsequently showed tumor reduction in >75% of the patients treated with fostrox + Lenvima. The tumor reduction correlated ...